Shamai S - Search Results

1

The use of medical cannabis concomitantly with immune checkpoint inhibitors in non-small cell lung cancer: A sigh of relief?

Waissengrin B, Leshem Y, Taya M, Meiri D, Merimsky O, Shamai S, Wolf I, Rubinek T. Waissengrin B, et al. Among authors: shamai s. Eur J Cancer. 2023 Feb;180:52-61. doi: 10.1016/j.ejca.2022.11.022. Epub 2022 Nov 29. Eur J Cancer. 2023. PMID: 36535195

2

Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data.

Dudnik E, Moskovitz M, Daher S, Shamai S, Hanovich E, Grubstein A, Shochat T, Wollner M, Bar J, Merimsky O, Zer A, Goldstein DA, Hammerman A, Cyjon A, Shechtman Y, Abu-Amna M, Flex D, Roisman LC, Peled N; Israel Lung Cancer Group. Dudnik E, et al. Among authors: shamai s. Lung Cancer. 2018 Dec;126:217-223. doi: 10.1016/j.lungcan.2017.11.015. Epub 2017 Nov 23. Lung Cancer. 2018. PMID: 29254746

3

Efficacy and safety of Nivolumab in non-small cell lung cancer patients in Tel-Aviv tertiary medical center: Facing the reality.

Shamai S, Merimsky O. Shamai S, et al. Mol Clin Oncol. 2018 Oct;9(4):419-422. doi: 10.3892/mco.2018.1693. Epub 2018 Aug 6. Mol Clin Oncol. 2018. PMID: 30214730 Free PMC article.

4

Trabectedin for Advanced Soft Tissue Sarcoma: Ten Year Real-Life Perspective.

Shamai S, Merimsky O. Shamai S, et al. Isr Med Assoc J. 2018 Oct;20(10):599-603. Isr Med Assoc J. 2018. PMID: 30324774 Free article.

5

Re-introducing immunotherapy in patients surviving immune checkpoint inhibitors-mediated myocarditis.

Peleg Hasson S, Salwen B, Sivan A, Shamai S, Geva R, Merimsky O, Raphael A, Shmilovich H, Moshkovits Y, Kapusta L, Rozenbaum Z, Wolf I, Laufer-Perl M. Peleg Hasson S, et al. Among authors: shamai s. Clin Res Cardiol. 2021 Jan;110(1):50-60. doi: 10.1007/s00392-020-01648-3. Epub 2020 Apr 15. Clin Res Cardiol. 2021. PMID: 32296970

6

Cardio-toxicity among patients with sarcoma: a cardio-oncology registry.

Shamai S, Rozenbaum Z, Merimsky O, Derakhshesh M, Moshkovits Y, Arnold J, Topilsky Y, Arbel Y, Laufer-Perl M. Shamai S, et al. BMC Cancer. 2020 Jun 30;20(1):609. doi: 10.1186/s12885-020-07104-9. BMC Cancer. 2020. PMID: 32605637 Free PMC article.

7

Innate inflammatory markers for predicting survival in retroperitoneal sarcoma.

Netanyahu Y, Gerstenhaber F, Shamai S, Sher O, Merimsky O, Klausner JM, Lahat G, Nizri E. Netanyahu Y, et al. Among authors: shamai s. J Surg Oncol. 2020 Dec;122(8):1655-1661. doi: 10.1002/jso.26178. Epub 2020 Aug 17. J Surg Oncol. 2020. PMID: 32808301

8

Severe Postoperative Complications are Associated with Impaired Survival in Primary but not in Recurrent Retroperitoneal Sarcoma.

Nizri E, Netanyahu Y, Gerstenhaber F, Shamai S, Sher O, Merimsky O, Lahat G, Klausner JM. Nizri E, et al. Among authors: shamai s. Ann Surg Oncol. 2021 May;28(5):2693-2699. doi: 10.1245/s10434-020-09179-x. Epub 2020 Oct 6. Ann Surg Oncol. 2021. PMID: 33025356

9

COVID-19 Vaccine-Induced Radiation Recall Phenomenon.

Soyfer V, Gutfeld O, Shamai S, Schlocker A, Merimsky O. Soyfer V, et al. Among authors: shamai s. Int J Radiat Oncol Biol Phys. 2021 Jul 15;110(4):957-961. doi: 10.1016/j.ijrobp.2021.02.048. Epub 2021 Mar 4. Int J Radiat Oncol Biol Phys. 2021. PMID: 33677050 Free PMC article.

10

Cancer Therapeutics-related Cardiac Dysfunction in Patients Treated With Immune Checkpoint Inhibitors: An Understudied Manifestation.

Peleg Hasson S, Arnold J, Merdler I, Sivan A, Shamai S, Geva R, Merimsky O, Shachar E, Waissengrin B, Moshkovits Y, Arbel Y, Topilsky Y, Rozenbaum Z, Wolf I, Laufer-Perl M. Peleg Hasson S, et al. Among authors: shamai s. J Immunother. 2021 Jun 1;44(5):179-184. doi: 10.1097/CJI.0000000000000371. J Immunother. 2021. PMID: 33950028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page